相似文献
1
Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.
J Med Chem. 2007 Oct 18;50(21):5176-82. doi: 10.1021/jm070255o. Epub 2007 Sep 22.
2
High-affinity carbamate analogues of morphinan at opioid receptors.
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1508-11. doi: 10.1016/j.bmcl.2007.01.013. Epub 2007 Jan 17.
3
Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
J Med Chem. 2004 Dec 16;47(26):6645-8. doi: 10.1021/jm040817t.
4
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ring.
J Med Chem. 2006 Oct 5;49(20):6104-10. doi: 10.1021/jm060595u.
5
Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.
ACS Chem Neurosci. 2013 Sep 18;4(9):1256-66. doi: 10.1021/cn4000428. Epub 2013 Jun 11.
6
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.
J Med Chem. 2009 Mar 12;52(5):1416-27. doi: 10.1021/jm801272c.
7
The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes.
Proc West Pharmacol Soc. 2002;45:32-5.
8
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
Eur J Pharmacol. 2005 Feb 21;509(2-3):117-25. doi: 10.1016/j.ejphar.2004.12.035.
9
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
Bioorg Med Chem. 2003 Sep 1;11(18):4143-54. doi: 10.1016/s0968-0896(03)00432-2.
10
Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
J Med Chem. 1998 Jul 16;41(15):2872-81. doi: 10.1021/jm980083i.
引用本文的文献
1
Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.
Molecules. 2022 Apr 30;27(9):2863. doi: 10.3390/molecules27092863.
2
Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.
Bioorg Med Chem Lett. 2013 Jul 1;23(13):3719-22. doi: 10.1016/j.bmcl.2013.05.027. Epub 2013 May 16.
3
Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects.
J Med Chem. 2012 Nov 26;55(22):9868-74. doi: 10.1021/jm301096s. Epub 2012 Oct 31.
4
Remodelling of the natural product fumagillol employing a reaction discovery approach.
Nat Chem. 2011 Dec;3(12):969-73. doi: 10.1038/nchem.1178.
5
Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418.
Acta Pharmacol Sin. 2011 Oct;32(10):1215-24. doi: 10.1038/aps.2011.83. Epub 2011 Aug 22.
6
Opioid receptors and the discriminative stimulus effects of ethanol in squirrel monkeys: Mu and delta opioid receptor mechanisms.
Eur J Pharmacol. 2011 Jan 10;650(1):233-9. doi: 10.1016/j.ejphar.2010.09.064. Epub 2010 Oct 15.
本文引用的文献
1
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ring.
J Med Chem. 2006 Oct 5;49(20):6104-10. doi: 10.1021/jm060595u.
2
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones.
J Med Chem. 2006 Aug 24;49(17):5333-8. doi: 10.1021/jm0604777.
3
The orvinols and related opioids--high affinity ligands with diverse efficacy profiles.
Curr Pharm Des. 2004;10(7):717-32. doi: 10.2174/1381612043453027.
4
Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.
Eur J Pharmacol. 2001 Sep 28;428(1):29-36. doi: 10.1016/s0014-2999(01)01282-1.
5
Structural determinants of efficacy for kappa opioid receptors in the orvinol series: 7,7-spiro analogues of buprenorphine.
J Med Chem. 2000 Jan 27;43(2):139-41. doi: 10.1021/jm991165p.
6
Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.
Eur J Pharmacol. 1997 Nov 12;338(3):215-23. doi: 10.1016/s0014-2999(97)81924-3.
7
Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Mol Pharmacol. 1995 Apr;47(4):848-54.
8
A classification of opiate receptors that mediate antinociception in animals.
Br J Pharmacol. 1980 Jul;69(3):503-12. doi: 10.1111/j.1476-5381.1980.tb07041.x.
9
A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
J Med Chem. 1980 Mar;23(3):233-4. doi: 10.1021/jm00177a002.
10
Novel analgesics and molecular rearrangements in the morphine-thebaine group. II. Alcohols derived from 6,14-endo-etheno- and 6,14-endo-ethanotetrahydrothebaine.
J Am Chem Soc. 1967 Jun 21;89(13):3273-80. doi: 10.1021/ja00989a031.
Zotero 插件